The "Global Radiopharmaceuticals Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of radiopharmaceuticals market with detailed market segmentation by applications, end user and geography. The global radiopharmaceuticals market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading radiopharmaceuticals market players and offers key trends and opportunities in the market.
Radiopharmaceuticals, or medicinal radiocompounds or nuclear medicines, are a group of pharmaceutical drugs which have radioactivity. These nuclear medicines can be used for diagnostic as well as therapeutic applications. Radiopharmaceuticals emit radiation themselves, which is different from contrast media which absorb or alter external electromagnetism or ultrasound. Radiopharmacology is the branch of pharmacology that specializes in these radiocompounds. The main group of these compounds are the radiotracers used to diagnose dysfunction in body tissues. While not all medical isotopes are radioactive, radiopharmaceuticals are the oldest and still most common such drugs.
Browse PDF Sample Report for in-depth Study@ https://www.theinsightpartners.com/sample/TIPRE00003751/
The radiopharmaceuticals market is anticipated to grow in the forecast, owing to the factors such increasing incidence and prevalence of target conditions, alpha radioimmunotherapy-based targeted cancer treatment and initiatives to lessen the demand-supply gap of Mo-99 in the market during the forecast period. However short life of the radiopharmaceuticals is hampering the market growth.
The reports cover key developments in the radiopharmaceuticals market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from radiopharmaceuticals market are anticipated to lucrative growth opportunities in the future with the rising demand for radiopharmaceuticals market in the global market. Below mentioned is the list of few companies engaged in the radiopharmaceuticals market.
The report also includes the profiles of key radiopharmaceuticals market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- CARDINAL HEALTH INC.
- GENERAL ELECTRIC COMPANY
- IBA GROUP
- LANTHEUS MEDICAL IMAGING
- COVIDIEN PLC
- POSITRON CORPORATION
- NTP RADIOISOTOPES PTY LTD.
- BRACCO IMAGING
- ADVANCED ACCELERATOR APPLICATIONS
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Ask for instant discount@https://www.theinsightpartners.com/discount/TIPRE00003751/
The global radiopharmaceuticals market is segmented on the basis of applications and end user and geography. Based on application, the market is segmented as diagnostic applications and therapeutic applications. On the basis of end user, the global radiopharmaceuticals market is segmented into, hospitals and diagnostic centers.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global radiopharmaceuticals market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The radiopharmaceuticals market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting radiopharmaceuticals market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the radiopharmaceuticals market in these regions.
Buy this report@https://www.theinsightpartners.com/buy/TIPRE00003751/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.
The Insight partners,
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.